Times Square Capital Management, LLC Deciphera Pharmaceuticals, Inc. Transaction History

Times Square Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$51.77 - $66.18 $25.4 Million - $32.5 Million	-490,400 Closed	0 $0
Q3 2020 Nov 06, 2020	SELL	$43.8 - $58.16 $3.07 Million - $4.08 Million	-70,130 Reduced 12.51%	490,400 $25.2 Million
Q2 2020 Aug 07, 2020	SELL	$37.05 - $65.03 $533,520 - $936,432	-14,400 Reduced 2.5%	560,530 $33.5 Million
Q1 2020 May 08, 2020	BUY	$33.63 - $69.4 $7.21 Million - $14.9 Million	214,515 Added 59.52%	574,930 $23.7 Million
Q4 2019 Feb 05, 2020	BUY	$31.7 - $69.93 $11.4 Million - $25.2 Million	360,415 New	360,415 $22.4 Million

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Times Square Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Times Square Capital Management, LLC with notifications on news.